UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Thrive Wealth Management LLC

Thrive Wealth Management LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.5% in the 4th quarter, Holdings Channel.com reports. The firm owned 1,798 shares of the healthcare conglomerate’s stock after selling 126 shares during the quarter. Thrive Wealth Management LLC’s holdings in UnitedHealth Group were worth $910,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Pacer Advisors Inc. boosted its position in shares of UnitedHealth Group by 5.7% in the 2nd quarter. Pacer Advisors Inc. now owns 65,860 shares of the healthcare conglomerate’s stock valued at $33,540,000 after purchasing an additional 3,525 shares during the period. Barrow Hanley Mewhinney & Strauss LLC grew its position in shares of UnitedHealth Group by 3.4% during the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 700,864 shares of the healthcare conglomerate’s stock worth $356,922,000 after acquiring an additional 23,129 shares during the last quarter. ProShare Advisors LLC raised its position in UnitedHealth Group by 7.9% in the 2nd quarter. ProShare Advisors LLC now owns 245,171 shares of the healthcare conglomerate’s stock valued at $124,856,000 after purchasing an additional 17,861 shares during the last quarter. Frank Rimerman Advisors LLC grew its position in UnitedHealth Group by 61,354.2% during the 2nd quarter. Frank Rimerman Advisors LLC now owns 14,749 shares of the healthcare conglomerate’s stock worth $7,511,000 after purchasing an additional 14,725 shares during the last quarter. Finally, 1832 Asset Management L.P. raised its holdings in shares of UnitedHealth Group by 12.0% in the second quarter. 1832 Asset Management L.P. now owns 1,797,607 shares of the healthcare conglomerate’s stock valued at $915,449,000 after buying an additional 192,128 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of several analyst reports. Royal Bank of Canada cut their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Truist Financial reduced their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday. Barclays dropped their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday. Finally, Morgan Stanley dropped their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Two investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Stock Down 0.1 %

UNH opened at $510.03 on Monday. The firm has a 50 day moving average price of $549.37 and a 200 day moving average price of $563.18. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The company has a market cap of $469.37 billion, a PE ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the firm earned $5.83 earnings per share. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.65%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.